8-chloro-11-piperidin-4-ylidene-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine, 99.00%, 100g

2-Bromo-1-fluoro-4-methoxybenzene, 95.0%, 500g

t-Butylglycine, 98.0%, 10g

3-Fluorophenylacetone, 95.0%, 25g

(R)-2-Hydroxy-2-phenylacetohydrazide, 95.0%, 100g

4-(Trifluoromethyl)benzaldehyde>95.0%(GC)5g

1-TERT-BUTYL 5-METHYL INDOLINE-1,5-DICARBOXYLATE, 95.0%, 100mg

4-((4-Boronophenyl)amino)-4-oxobutanoic acid, 98%, 250mg

2-(3-Chloro-5-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 250mg

5-Amino-2,3-difluorobenzoic acid, 95.0%, 100mg

tert-Butyl 3',3'-difluoro-[1,4'-bipiperidine]-1'-carboxylate, 97%, 250mg

(S)-(+)-DBD-Py-NCS [=(S)-(+)-4-(N,N-Dimethylaminosulfonyl)-7-(3-isothiocyanatopyrrolidin-1-yl)-2,1,3-benzoxadiazole] [for HPLC Labeling]>98.0%(HPLC)500mg

4-Bromo-3-methoxybenzene-1,2-diamine, 97%, 1g